Pharmacist-physician drug communications.

J Am Pharm Assoc

Published: April 1971

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0003-0465(16)31585-3DOI Listing

Publication Analysis

Top Keywords

pharmacist-physician drug
4
drug communications
4
pharmacist-physician
1
communications
1

Similar Publications

Article Synopsis
  • The study aimed to assess how effective pharmacist-physician collaboration is in optimizing antimicrobial treatment for aspiration pneumonia patients.
  • Group B patients who followed the antimicrobial protocol had better outcomes, showing fewer cases of underdosing and shorter hospital stays compared to Group A, which did not follow the protocol.
  • Overall, the results indicate that using structured treatment protocols enhances patient care and could be beneficial for managing aspiration pneumonia, particularly as the population ages.
View Article and Find Full Text PDF

Introduction: Pharmaceutical Intervention aims to optimize and rationalize the use, effectiveness, and safety of dispensed medications resolving drug-related problems (DRPs) and negative medicine outcomes (NMOs).

Objectives: To evaluate Pharmaceutical Interventions in Benzodiazepines users during the COVID-19 pandemic from a Community Pharmacy.

Method: Prospective observational, descriptive, and cross-sectional study (AEMPS code: DAA-CLO-2020-01) of Pharmaceutical Interventions offered by the community pharmacy between August 2020 and February 2021.

View Article and Find Full Text PDF

Purpose: This report describes the step-by-step process that led to expansion of ambulatory care pharmacy services at a newly established internal medicine clinic within a patient-centered medical home in North Carolina.

Summary: Implementation of clinical pharmacist services at the clinic was led by a postgraduate year 2 (PGY2) pharmacy resident and guided by the 9 steps described in the book Building a Successful Ambulatory Care Practice: A Complete Guide for Pharmacists. After a needs assessment and review of the demographics and insurance status of the clinic's target population, it was determined that pharmacist services would focus on quality measures including diabetes nephropathy screening, diabetes eye examination, blood glucose control in diabetes, discharge medication reconciliation, annual wellness visits, and medication adherence in diabetes, hypercholesterolemia, and hypertension.

View Article and Find Full Text PDF

Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs.

Drug Alcohol Depend Rep

March 2024

Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle WA, United States.

Background: People who inject drugs (PWID) are a key population for treatment with direct-acting antiviral medications (DAAs) to eliminate hepatitis C virus (HCV). We developed a Pharmacist, Physician, and Patient Navigator Collaborative Care Model (PPP-CCM) for delivery of HCV treatment; this study describes clinical outcomes related to HCV treatment (initial evaluation, treatment initiation, completion, and cure), as well as patient satisfaction.

Methods: We conducted a single-arm prospective pilot study of adult PWID living with HCV.

View Article and Find Full Text PDF

Introduction: Increasing administrative workload is linked with lower quality of patient care and physician burnout. Conversely, models involving pharmacists can positively impact patient care and physician well-being. Research has consistently demonstrated that pharmacist-physician collaboration can improve outcomes for chronic diagnoses.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!